OrthoPediatrics (KIDS) reported Monday preliminary Q4 net revenue of $52.7 million, up from $37.6 million a year earlier.
Analysts polled by FactSet expect $50.7 million.
The company expects 2025 revenue of $235 million to $242 million, up 15% to 18% from the preliminary figure of $204.7 million.
Analysts surveyed by FactSet project $239.9 million.
OrthoPediatrics plans to release Q4 and 2024 results in early March.
Price: 25.44, Change: +0.44, Percent Change: +1.76
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。